Are Infrared Light Therapy Pain Treatments Safe and Effective?

The Science of Infrared Light and Pain Relief

Chronic pain costs the US economy over $635 billion annually and affects more than 50 million adults. For many, conventional options — NSAIDs, opioids, physical therapy — provide incomplete relief or come with significant side effects. Near-infrared (NIR) light therapy has emerged as a non-invasive, drug-free alternative with a growing clinical evidence base. But is it actually safe? And does it actually work?

The short answers: yes, and yes — within specific parameters and for specific types of pain. Here's what the research shows.

How Near-Infrared Light Reaches Pain at Its Source

Near-infrared wavelengths (typically 810–850 nm) penetrate human tissue to depths of 3–5 centimeters — deep enough to reach muscles, tendons, ligaments, and joint structures that are inaccessible to topical treatments. Once absorbed, the light triggers several pain-relevant biological processes:

• Reduced pro-inflammatory cytokines — NIR light suppresses TNF-α, IL-1β, and IL-6, key drivers of inflammatory pain
• Increased endorphin release — light-stimulated cells upregulate endogenous opioid peptides, contributing to pain modulation
• Nerve conduction modulation — NIR light can temporarily reduce the firing rate of C-fiber pain neurons (the slow, burning pain fibers)
• Increased ATP in damaged cells — re-energizing injured tissue accelerates the cellular repair processes that underlie pain resolution
• Nitric oxide release — improves local microcirculation, reducing hypoxia-related pain in chronic conditions

Clinical Evidence by Pain Type

Osteoarthritis

This is one of the most studied applications. A 2009 systematic review in the Journal of Rheumatology (Bjordal et al.) analyzed 22 trials and concluded that low-level laser/light therapy provided significant short-term pain relief for knee osteoarthritis, reducing pain scores by a clinically meaningful margin. Follow-up studies using LED panels (rather than lasers) at NIR wavelengths have confirmed comparable benefits — relevant because LED-based home devices like AWA panels use the same wavelength range.

Rheumatoid Arthritis

A Cochrane systematic review (Brosseau et al.) found that low-level light therapy significantly reduced pain and morning stiffness in rheumatoid arthritis patients compared to placebo. The effect was most pronounced in the hand and wrist joints. Reductions in hand joint tenderness were particularly consistent.

Neck and Back Pain

Multiple RCTs have shown significant reduction in chronic neck pain with photobiomodulation. A 2009 Lancet meta-analysis of 16 trials found NIR/red light therapy reduced neck pain intensity and disability at short- and intermediate-term follow-up. For lower back pain, evidence is positive but less consistent — the variability appears to relate to dosing protocols rather than efficacy doubt.

Neuropathic Pain

Perhaps the most promising emerging application. NIR light applied along peripheral nerve pathways has shown ability to reduce pain in diabetic peripheral neuropathy (Zinman et al., 2004), carpal tunnel syndrome (Naeser et al.), and post-herpetic neuralgia. The mechanism appears to involve both anti-inflammatory effects and direct modulation of neural excitability.

Post-Surgical and Acute Musculoskeletal Pain

NIR light applied post-surgically accelerates tissue healing and reduces the inflammatory pain phase. Studies in dental, orthopedic, and soft-tissue surgery contexts all show reduced post-operative pain and swelling with perioperative light therapy application.

Is It Safe? The Complete Safety Profile

Near-infrared light therapy has an excellent safety profile when used correctly. Here's the evidence-based safety assessment:

What Is Safe

• Applying NIR light to muscles, joints, the back, neck, and extremities at recommended distances and durations
• Daily use over extended periods — no evidence of cumulative harm from repeated exposure at therapeutic parameters
• Use alongside medications — NIR light does not interact with common pain medications, NSAIDs, or most prescription drugs
• Use by most age groups — used safely in pediatric, adult, and geriatric populations in clinical settings

Genuine Precautions

• Eyes: Do not direct NIR light at open eyes at therapeutic intensities — always use eye protection or close eyes
• Active cancer sites: Avoid applying directly over known tumor locations pending consultation with oncologist
• Photosensitizing medications: Some medications (certain antibiotics, diuretics, chemotherapy agents) increase tissue photosensitivity — consult prescribing physician
• Pregnancy: Limited data; generally considered safe but avoid direct abdominal exposure during first trimester as a precaution
• Implanted devices: Metal implants (joint replacements, plates) are generally safe; active electronic implants (pacemakers, neurostimulators) — consult physician before treating nearby areas
• Thermal injury: At very close range (<2 inches) for extended periods, NIR devices can cause skin warming and potential burns. Follow manufacturer distance guidelines.

Protocol for Pain Management with AWA Devices

For effective pain management, the key variables are wavelength, distance, session duration, and placement:

• Wavelength: 850 nm NIR is the primary workhorse for pain; combined 660+850 nm is also effective
• Distance: 2–6 inches for small joint targets (fingers, wrist, ankle); 6–12 inches for larger areas (knee, shoulder, back)
• Duration: 10–20 minutes per target area per session
• Frequency: Daily for acute pain; 3–5×/week for chronic management
• Placement: Directly over the pain source when possible; for deep structures (hip joint), position over the overlying tissue at the closest practical angle

AWA Device Recommendations by Pain Type

• Hand/wrist/elbow pain: AWA FX300 or LX300 — compact size allows precise positioning; sessions 10–15 min
• Knee/shoulder pain: AWA FX300/LX300 at 4–8 inches; or FX500/LX500 for larger coverage
• Lower back/full back: AWA FX500 or LX500 — full panel covers the lumbar and thoracic regions simultaneously; sessions 15–20 min
• Neck pain: AWA FX300 or LX300 positioned at the back of the neck; 10–15 min
• Neuropathic pain (feet, lower legs): AWA FX500 at 6–12 inches, covering the affected limb; 15–20 min

How Quickly Does It Work?

Pain relief timelines vary by condition and severity:

• Acute musculoskeletal injury: Many users notice reduced soreness and stiffness within 24–48 hours of initial sessions
• Joint osteoarthritis: Clinical trials show significant pain reduction typically at 3–6 weeks of consistent treatment
• Chronic neuropathic pain: Slower response; 8–12 weeks of consistent use is the minimum for meaningful assessment
• Inflammatory arthritis (RA): Morning stiffness often improves within 2–3 weeks; sustained improvement develops over 6–8 weeks

The Bottom Line

Near-infrared light therapy for pain is both safe (at recommended parameters) and effective (with strong clinical evidence for arthritis, neck pain, neuropathy, and musculoskeletal conditions). It works through direct biological mechanisms — anti-inflammatory, neuromodulatory, and tissue-repair pathways — not placebo. The key is consistent use at appropriate dose with a device that actually delivers sufficient irradiance at validated NIR wavelengths. AWA's FX300, FX500, LX300, and LX500 are designed to meet those parameters.

If you're managing chronic pain and looking for a non-pharmacological option with a strong safety profile and genuine evidence base, near-infrared light therapy deserves serious consideration.